Baird Industrials Conference Investor Presentation November 2016 - - PowerPoint PPT Presentation

baird industrials conference investor presentation
SMART_READER_LITE
LIVE PREVIEW

Baird Industrials Conference Investor Presentation November 2016 - - PowerPoint PPT Presentation

Baird Industrials Conference Investor Presentation November 2016 Forward Looking Statements Forward Looking Statements These slides contain (and the accompanying oral discussion will contain) forward looking statements. All statements


slide-1
SLIDE 1

Baird Industrials Conference Investor Presentation

November 2016

slide-2
SLIDE 2

Forward‐Looking Statements

Forward Looking Statements These slides contain (and the accompanying oral discussion will contain) “forward‐looking statements”. All statements other than statements of historical fact or relating to present facts or current conditions are forward‐looking statements. In many cases, you can identify forward‐looking statements by terms such as “may,” “will,” “should,” “expected,” “plan,” “anticipates,” “believes,” “estimates,” predicts,” “potential” or other comparative terminology. Such statements involve known and unknown risks, uncertainties and other factors that could cause the actual results of the Company to differ materially from the results expressed or implied by such statements, including general economic and business conditions, conditions affecting the industries served by the Company and its subsidiaries, conditions affecting the Company’s customers and suppliers, competitor responses to the Company’s products and services, the overall market acceptance of such products and services, increases in the Company’s cost structure, the rate of economic development and growth in emerging markets, the Company’s exposure to fluctuations in currencies, the Company’s ability to successfully implement its strategic initiatives to increase cost savings and improve operating margins, the integration of acquisitions and other factors disclosed in the Company’s Form 10‐K including those described under the headings “Risk Factors” and “Forward‐Looking Statements.” Consequently, such forward‐looking statements should be regarded as the Company’s current plans, estimates and beliefs. Any financial projections are based on contingencies that are beyond the Company’s control. Actual results during the period or periods covered by such projections may differ significantly from the projected results and no assurance can be given that the projected results will be realized. The Company does not undertake and specifically declines any obligation to publicly release the results of any revisions to these forward‐looking statements that may be made to reflect any future events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events. All of the Company’s forward‐looking statements should be considered in light of these factors. Non‐GAAP Financial Measures The historical financial information included in this presentation includes financial information that is not presented in accordance with generally accepted accounting principles in the United States (“GAAP”), including Adjusted Net Income, Adjusted Operating Income, Adjusted EBITDA, Free Cash Flow and Free Cash Flow Yield. Management uses these non GAAP financial measures in the analysis of financial and operating performance because they assist in the evaluation of underlying trends in our business. Our use of the terms Adjusted Net Income, Adjusted Operating Income, and Adjusted EBITDA, Free Cash Flow and Free Cash Flow Yield may differ from that of others in our industry. These items should not be considered as alternatives to net income (loss), operating income (loss), or any other performance measures prepared in accordance with GAAP as measures of operating performance or operating cash flows or as measures of liquidity. Adjusted Net Income, Adjusted Operating Income, and Adjusted EBITDA have important limitations as analytical tools and should be considered in conjunction with, and not as substitutes for, our results as reported under GAAP. This presentation includes a reconciliation of certain non GAAP financial measures with the most directly comparable financial measures calculated in accordance with GAAP. Market and Industry Data This presentation also contains market data and other statistical information that are based on independent industry publications, reports by market research firms or published independent sources. Some market data and statistical information are also based on the Company’s good faith estimates, which are derived from management’s knowledge of its industry and such independent sources referred to above. While the Company is not aware of any misstatements regarding its market and industry data presented herein, such data involve risks and uncertainties and are subject to change based on various factors, including those discussed under the heading “Risk Factors” in the Company’s Form 10‐K. Long‐Term Goals Disclaimer This presentation includes long‐term goals that are forward‐looking, are subject to significant business, economic, regulatory and competitive uncertainties and contingencies, many

  • f which are beyond the control of the Company and its management, and are based upon assumptions with respect to future decisions, which are subject to change. Actual results

will vary and those variations may be material. For discussion of some of the important factors that could cause these variations, please consult the “Risk Factors” section of the Company’s Form 10‐K. Nothing in this presentation should be regarded as a representation by any person that these goals will be achieved and the Company undertakes no duty to update its goals.

1

slide-3
SLIDE 3

47% 47% 6%

North America Asia Europe

47% 47% 6%

North America Europe Asia 61% 14% 8% 6% 11% Premium Folding Cartons Rigid Packaging Other Labels Inserts

Geography Geography

61% 13% 8% 6% 12%

Premium Folding Cartons Other Rigid Packaging Labels Inserts

50% 39% 11% 50% 40% 10%

Net Sales $1,661 $1,610

  • Adj. EBITDA

$254 $237

  • Adj. EBITDA Margin

15.3% 14.7% Free Cash Flow (2) $78 $65

  • Adj. Free Cash Flow (3)

$113 $101

Company Overview

 A leading global provider of specialty packaging

solutions

― High value‐added products and services for the

consumer, healthcare and multi‐media end markets

― Frontline of branding, product integrity and regulatory

compliance

― $15+ bn market opportunity with leading positions ― Diverse customer base with long‐term relationships

with major pharma, consumer and media customers

― Global footprint of 59 sites in North America, Europe

and Asia (1)

 Financial Highlights

Note: Dollars in millions. (1) As of 6/30/2016. Does not take into consideration FY17 acquisitions or announced reorganization activities. (2) Free Cash Flow is defined as cash provided by operating activities (a GAAP measure) less capital expenditures, plus proceeds from sale of assets. (3) Adjusted Free Cash Flow is defined as adjusted EBITDA plus proceeds from sale of assets, less capital expenditures, cash interest, cash taxes, changes in working capital, and pension payments.

End Market End Market Product Product TTM 9/30/16 Fiscal Year Ended 6/30/16

Multi‐Media Healthcare Consumer Consumer Healthcare Multi‐Media 2

Net Sales as of: Fiscal Year ended 6/30/16 TTM 9/30/16

slide-4
SLIDE 4

Strategically Built Platform…

Build Build Transform Transform Add‐On Strategic Add‐On Strategic

July 2005 April 2006 April 2006 February 2008 March 2008 Belgium 2008 Idaho Falls 2010 April 2014 November 2014 April 2009 June 2011 Merged February 2014 April 2014 February 2015 July 2014 July 2015

Printing and Packaging

 Establish presence in core products and end markets in North America  Create global specialty packaging leader serving customers worldwide  Expand and deepen geographic and product footprint

Transactions focused on penetrating new end markets, geographies and adding manufacturing processes and technologies

MPS has completed 18 transactions since 2005

January 2016 January 2005 October 2016 November 2016 3

slide-5
SLIDE 5

…Well‐Positioned to Serve Our Customers Globally…

Truly Global Manufacturing Footprint (1)

33 Manufacturing Facilities 33 Manufacturing Facilities 47% of Sales 47% of Sales 47% of Sales 47% of Sales 6% of Sales 6% of Sales 23 Manufacturing Facilities 23 Manufacturing Facilities 3 Manufacturing Facilities 3 Manufacturing Facilities

North America Asia Europe

(1) Percentages based on total sales on a TTM basis through 9/30/2016. Site locations are as of 6/30/2016. Does not take into consideration FY17 acquisitions or announced reorganization activities.

 Over $320mm in capex invested in manufacturing

platform over the last 5 years to provide: ― Scale & geographic coverage ― Operational flexibility, enhanced productivity ― Security of redundant capabilities ― Site accreditation

 Commitment to LEAN manufacturing

― Six LEAN coordinators ― 50%+ of employees trained on LEAN

 Annual capex to sales in a range of 3.0% to 3.7% Well‐Invested Asset Base

4

slide-6
SLIDE 6

$231 $266 $253 $100 $150 $200 $250 $300 FY 2015 FY 2016 TTM 9/30/2016

FX Impact FX Impact

77% Cash Flow Conversion 78% Cash Flow Conversion

$254

…Resulting in Strong Growth, Margin and Cash Flow Conversion (1)

  • Adj. EBITDA

(1) Cash flow conversion is defined as adjusted EBITDA less capital expenditures divided by adjusted EBITDA.

(3)

5

74% Cash Flow Conversion

$237

slide-7
SLIDE 7

Consumer Healthcare Multi‐Media TTM 9/30/2016 % of Sales 50% 40% 10% Industry Market Growth in Units (1) 2015E – 2020E CAGR 2% 6% (15)% Key Strategy

 Invest for growth  Invest for growth  Manage for cash

Key Drivers

 Brand differentiation  Product innovation  Rapid refresh cycles  Premiumization  Demographics  Product innovation  Rapid refresh cycles  Product proliferation  Regulatory requirements  Commemorative, special editions  Product innovation  Games and gaming platforms

(1) Management estimates.

Large, Stable End Markets

Consumer and Healthcare ~90% of sales, with mix shift accelerating in the near term

6

slide-8
SLIDE 8

Addressable Market Opportunity (1)

A Global Market Leader in Fragmented Industry

MPS TTM 09/30/16 Net Sales Mix

$15+ Billion Incremental Market Opportunity for MPS

Note: Dollars in millions unless otherwise noted. (1) Addressable market opportunity based on management estimates. (2) Does not include approximately $200M incremental addressable market opportunity in Europe.

Clear runway to attack $15+ billion incremental market opportunity

~$8+bn ~$17+bn ~$8+bn ~$0.3+bn Consumer Healthcare Media Total

(2)

7

$814 $1,610 $636 $160 Consumer Healthcare Media Total

slide-9
SLIDE 9

A Global Market Leader in Fragmented Industry (Cont’d)

Broad array of value‐added premium products…

Premium Folding Cartons Inserts Labels Rigid Packaging Other Consumer Packaging FY 2016 % of Sales 61% 13% 8% 6% 12% Products

8

slide-10
SLIDE 10

Manage customers' digital assets Manage customers' digital assets Digital Workflow Digital Workflow Creative Services Creative Services Structural and graphic design team Structural and graphic design team Pre‐Press Services Pre‐Press Services Around‐the‐clock team for same day or next day service Around‐the‐clock team for same day or next day service VMI / EDI VMI / EDI Manage production based on customer demand; interface directly with customers’ IT systems Manage production based on customer demand; interface directly with customers’ IT systems Late Stage Customization Late Stage Customization Customized products on‐demand Customized products on‐demand Co‐Located Facilities Co‐Located Facilities Equipment and staffing for printing and packaging production located within customers' facilities Equipment and staffing for printing and packaging production located within customers' facilities Brand Protection Brand Protection Magnetic inks, invisible bar codes, holographic cold foil Magnetic inks, invisible bar codes, holographic cold foil

A Global Market Leader in Fragmented Industry (Cont’d)

…Supported by a comprehensive services platform

9

slide-11
SLIDE 11

Untapped Cross‐Sell Potential

Cross‐Sell Potential Premium Confectionary Customer Case Study

Graphic/Design Rigid Box Booklet

Product Cross‐Sell ‐ Bosch Geographic Cross‐Sell

Strategically positioned to serve growing global customers and gain share

 The customer is a global provider of high end premium confectionery products (“Customer X”)  MPS has been a leading provider to them in Germany, and offers a unique in line metallized product combined with unique low migration inks

Leading Product Development Capabilities and Speed‐to‐Market

High‐End Premium Packaging Solutions

Unique Global Footprint and Design Capabilities

 As the customer continues to expand globally, the need to have a supplier who can offer these unique elements in a timely and consistent way across the globe creates an opportunity for the customer and MPS to work together  Through the merger of MPS and Chesapeake, and the later acquisition

  • f ASG, MPS provides a unique footprint available to this customer,

allowing MPS to offer this unique combination of technology and service in China, Germany, Poland, the United States, and France

MPS continues to expand serving global customers

6%

92% 19% 70% 10%

10

Customer X Sales

2015 2016

China Germany Poland France United States

slide-12
SLIDE 12

Next Generation and Innovation

11

Supply Chain Supply Chain Printing Printing Cutting & Folding Cutting & Folding Gluing Gluing Assembly Assembly Special Applications Special Applications

E‐Inks Near Field Communication

Child Resistant & Tamper Evident

Electro‐Luminescence LED Augmented Reality Capacitive Touch

slide-13
SLIDE 13

Diverse, Blue Chip Customer Base

…with no customer concentration (1)

4% 4% 3% 3% 2% 9% 75% All Other Customer 6‐10 Customer 4 Customer 1 Customer 2 Customer 3 Customer 5

A key partner in our customers’ supply chain…

 Long‐term customer relationships with significant cross‐

selling opportunities across products and geographies

 Average length of relationship with our top 20 customers

exceeds 34 years

 Risk averse customer set focused on suppliers with high

quality products and service capabilities

Multi‐Media Healthcare Consumer Largest customer represents 4% of sales

(1) As of June 30, 2016.

12

slide-14
SLIDE 14

Recent Transactions

  • Supplies high quality self‐adhesive labels

to the Beauty and Personal Care, Confectionery, Beverage and Household sectors.

  • Employs approx.. 80 people, are an

award‐winning supplier to a wide range

  • f blue chip multinational and UK

customers.

  • Based in Littlehampton, United

Kingdom.

  • Offers a fully‐integrated solution for

creating and personalizing plastic transaction cards including pre‐paid gift and loyalty cards.

  • Pioneered new in‐line production

techniques that offer customers improved delivery time, quality and increased product security.

  • Based in Dallas, Texas.

Proven Acquisition Track Record

Broad Opportunity Set of Potential Targets

 MPS has an ~10% share of a $17+bn addressable

market(1)

 18 transactions since 2005, 17 of which identified

by management outside a formal process

 Attractive acquisition multiples both pre‐ and post‐

synergies

 Track record of achieving and exceeding synergy

targets Successful Track Record

<$50 million $50 ‐ $200 million $200+ million

Size Range by Target Sales

~15+ ~8+ ~4+ ~$400mm ~$600mm ~$2,000mm # of Companies Aggregate Sales MPS has ongoing dialogues with multiple targets

(1) As of June 30, 2016.

13

slide-15
SLIDE 15

Favorable Mix Shift Incremental Synergies from Completed Acquisitions Value‐Added Products, Servicing Attractive End Markets Operational Discipline Efficiency Capex

Attractive Margins with Upside Opportunities

Strong Margins with Defined Path for Improvement Facility Rationalization

14

slide-16
SLIDE 16

…Resulting in Strong Margin and Cash Flow

15

Long‐term Adj. EBITDA Margin Potential

.

13.5% +17.0% 0.6% +1.7% 1.2% 15.3%

12% 13% 14% 15% 16% 17% 18% Pro Forma FY'2015 FY'2016 Activity Pro Forma FY'2016 Target Improvement Long term target

Operational Improvements Acquisition Synergies

slide-17
SLIDE 17

Quarter Ended 9/30/16 Update

  • Adj. EBITDA

Gross Profit

Note: Dollars in millions. MPSX fiscal year end June 30th. (1) Free Cash Flow is defined as cash provided by operating activities (a GAAP measure) less capital expenditures, plus proceeds from sale of assets. (2) Adjusted Free Cash Flow is defined as adjusted EBITDA plus proceeds from sale of assets, less capital expenditures, cash interest, cash taxes, changes in working capital, and pension payments. (3) Free Cash Flow Conversion is defined as Adjusted EBITDA less capital expenditures divided by adjusted EBITDA.

Adjusted Free Cash Flow (3) Net Sales Commentary

FX Impact FX Impact

$459 $425

Q1 FY'16 Q1 FY'17

$99 $84

$0.0 $20.0 $40.0 $60.0 $80.0 $100.0 $120.0

Q1 FY'16 Q1 FY'17

$30 $17 Q1 FY'16 Q1 FY'17

$77 $63

Q1 FY'16 Q1 FY'17 16

 Net sales declined by approximately 4%

due to:

Negative FX impact of $17

Lower North American sales due to decline in media sales, and health care customers experiencing weaker sales (not lost customers)

Lower European sales principally due to FX headwinds following Brexit and weakness in the European drinks market

 Adjusted EBITDA of $60 million vs. $77

million

Adjusted EBITDA margin of 14.7%

  • vs. 16.8%

 Free Cash Flow (1) of $8 million vs. $21

million

 Adjusted Free Cash Flow (2) of $17 million

  • vs. $30 million

Recent Activity

 Completed debt refinancing transaction

in October 2016

 Completed two acquisitions in October

2016 with combined trailing 12 months revenue of $25 million

 Announced plant reorganizations

84% Cash Flow Conversion 89% Cash Flow Conversion

slide-18
SLIDE 18

FX Overview

FX Detail FY ‘16 by Currency

 Our FX exposure is primarily translational in nature

― In most circumstances, sales and costs are denominated in

matching currency which create natural hedges

 Beginning in January 2015, changes in FX exchange rates began

to significantly impact sales

― Sales were negatively impacted by ~$77 million for fiscal 2016

as compared to fiscal 2015

― On a constant currency basis using average exchange rates for

2014, the past two years sales have been negatively impacted by more than ~$230 million cumulatively. EBITDA was impacted in the same period by ~$32 million cumulatively

― Continued weakness in foreign currency rates, primarily the

GBP during Q1 fiscal 2017 negatively impacted net sales by ~$17 million as compared to Q1 fiscal 2016. These headwinds are expected to continue throughout the remainder of fiscal 2017

  • Our borrowings include USD, GBP, and EUR term loans

intended to naturally hedge the cash flows of the business

17

CAD 4% CNY 5% EUR 18% GBP 27% HKD 1% MXN 1% PLN 2% USD 42%

Sales

slide-19
SLIDE 19

Strong, Growing FCF Profile

 Significant debt reduction from free cash flow and

IPO

― Results in a reduction of the cash interest run

rate to $41 ‐ $42 million per year subsequent to October 2016 refinancing

― Low capex requirements: 3.0% to 3.7% of net

sales

 Disciplined approach to capital investment  Significant impact of NOLs in excess of $100mm (1)

― $86mm relates to US Federal and state NOLs ― Remainder principally in foreign jurisdictions

Note: Dollars in millions. (1) As of June 30, 2016. (2) Based on management estimates keeping all other components of free cash flow constant. (3) Other not specifically identified. (4) Based on 77,452,946 common shares outstanding as of September 30, 2016.

Pro Forma Free Cash Flow Free Cash Flow Drivers since IPO

LTM 9/30/16 Adj. EBITDA: $237 Less: Annual Capex (60) Less: Annual Cash Interest (41) ‐ (42) Less: Annual Cash Taxes (13) ‐ (15) Less: Annual changes in core working capital (5) ‐ (10) Less: Other (3) (3) ‐ (5)

  • Adj. Free Cash Flow

$105 ‐ $115

  • Adj. Free Cash Flow per Share (4)

$1.36 ‐ $1.48

Every 100 bps of Adj. EBITDA Margin expected to result in incremental $0.21 of Free Cash Flow per Share(2)

18

slide-20
SLIDE 20

Continued Balance Sheet Improvement

Flexible, Long‐Dated Capital Structure Significant Reduction in Annualized Cash Interest

Note: Dollars in millions. Outstanding debt balances exclude debt discounts. (1) Includes Capital Leases and Foreign Debt. (2) Adjusted EBITDA does not include i3 plastic cards or AJS labels. (3) The pro forma column includes new term loan D borrowing of $220mm, the proceeds of which were used to redeem the $200mm, 8.5% notes as well as pay debt extinguishment charges and related expenses.

$60 $41 ‐ $42 FY' 2016 Pro forma annual run rate

Pre‐IPO Current Pro forma Capitalization Maturity 30‐Jun‐15 30‐Sep‐16 30‐Sep‐16 Cash and equivalents – $56 $51 $51 Term loans Sep‐20 $994 $717 $717 New term loan Sep‐23 $0 $0 $220 Other debt (1) Various $14 $2 $2 8.500% Senior Unsecured Notes Aug‐21 $200 $200 $0 Total debt $1,208 $919 $939 Pre‐IPO LTM Pro forma LTM Credit statistics 30‐Jun‐15 30‐Sep‐16 30‐Sep‐16

  • Adj. EBITDA (2)

$231 $237 $237 Cash interest expense $71 $57 $41 ‐ $42 Total debt / Adj. EBITDA 5.2x 3.9x 4.0x Net debt / Adj. EBITDA 5.0x 3.7x 3.7x

  • Adj. EBITDA / Cash interest expense

3.3x 4.2x 5.8x

19

slide-21
SLIDE 21

Attractive EBITDA growth and cash conversion

 Leverage positions in growing end markets  Convert pipeline of acquisition targets  Drive margin upside through operational

excellence and synergy realization

 Capital discipline

MPS’ Strategy Drives Attractive EBITDA Growth and Cash Conversion

1 2 3 4

Goal of 2% ‐ 3% organic net sales growth (1) product/end market mix shift accelerating growth in the near term; continued share gain $50 ‐ $100mm in acquisitions per annum at average 4x post‐synergy multiple Goal of 17%+ targeted Adj. EBITDA margins Favorable Free Cash Flow characteristics

Long‐Term Goals Disclaimer: This presentation includes long‐term goals that are forward‐looking, are subject to significant business, economic, regulatory and competitive uncertainties and contingencies, many of which are beyond the control of the Company and its management, and are based upon assumptions with respect to future decisions, which are subject to

  • change. Actual results will vary and those variations may be material. For discussion of some of the important factors that could cause these variations, please consult the “Risk Factors”

section of the preliminary prospectus. Nothing in this presentation should be regarded as a representation by any person that these goals will be achieved and the Company undertakes no duty to update its goals. (1) Excluding media and tobacco, assuming a constant currency, and excluding acquisitions.

20

slide-22
SLIDE 22

Awarded in the UK ‐ Packaging Company of the Year!

21

slide-23
SLIDE 23

Appendix

slide-24
SLIDE 24
  • Adj. EBITDA to Net Income Reconciliation

Non-GAAP Adjusted EBITDA

(amounts in thousands)

Consolidated net income $ 4,590 $ 7,026 $ 12,869 $ 13,084 Depreciation and amortization 129,000 131,703 29,441 33,311 Interest expense 64,543 75,437 14,642 18,729 Income tax expense 4,592 (1,880) 3,152 5,231 EBITDA 202,725 212,286 60,104 70,355 Adjustments related to operating income Transaction related expenses 3,838 13,630 284 350 Stock based and deferred compensation expenses 26,818 5,722 309 (272) Purchase accounting adjustments 966 3,094 228 331 Restructuring related costs 10,684 6,419 2,868 2,826 Loss on sale of fixed assets 1,410 584 107 194 Other adjustments to operating income (2,741) (1,928) (907) (455) Adjustments related to operating income (A) 40,975 27,521 2,889 2,974 Adjustments related to non-operating income Foreign currency (gains) losses 5,183 (12,171) (2,440) 2,867 Debt extinguishment charges 3,968 1,019 — — Other adjustments to non-operating income 1,452 2,307 (497) 1,000 Adjustments related to non-operating income 10,603 (8,845) (2,937) 3,867 Total adjustments (B) 51,578 18,676 (48) 6,841 Adjusted EBITDA $ 254,303 $ 230,962 $ 60,056 $ 77,196 Pre-acquisition Adjusted EBITDA 851 16,172 — 297 Proforma Adjusted EBITDA $ 255,154 $ 247,134 $ 60,056 $ 77,493

For the Twelve Months Ended Three Months Ended June 30, September 30, 2016 2015 2016 2015

23

slide-25
SLIDE 25

Adjusted Operating and Adjusted Net Income Reconciliation

(A) ‐ (B) See related total reconciled on Adjusted EBITDA reconciliation.

Non-GAAP Adjusted Net Income

(amounts in thousands, except per share data)

Consolidated net income $ 4,590 $ 7,026 $ 12,869 $ 13,084 Adjustments related to net income (B) 51,578 18,676 (48) 6,841 Tax impact of adjusting entries (8,773) (3,496) (145) (1,743) Adjusted net income 47,395 22,206 12,676 18,182 Net loss (income) attributable to noncontrolling interest 805 (527) 380 (77) Adjusted net income attributable to shareholders of Multi Packaging Solutions International Limited $ 48,200 $ 21,679 $ 13,056 $ 18,105 Weighted average number of common shares outstanding – diluted 72,661 61,939 77,453 61,939 Adjusted net income per share $ 0.66 $ 0.35 $ 0.17 $ 0.29

June 30, September 30, For the Twelve Months Ended Three Months Ended 2016 2015 2016 2015

24

Non-GAAP Adjusted Operating Income

(amounts in thousands)

Operating income $ 27,726 $ 40,679 $ 27,726 $ 40,679 Adjustments related to operating income (A) — — 2,889 2,974 Adjusted operating income $ 27,726 $ 40,679 $ 30,615 $ 43,653

For the Three Months Ended Three Months Ended September 30, September 30, 2016 2015 2016 2015

slide-26
SLIDE 26

Historical Financial Summary ‐ Markets

25

(amounts in millions)

Consumer $ 216 $ 233 $ 894 $ 816 Healthcare 156 158 663 644 Multi-Media 53 68 181 158 FX Impact (17) — (77) —

Net Sales

$ 408 $ 459 $ 1,661 $ 1,618 Consumer $ 206 $ 233 $ 841 $ 816 Healthcare 154 158 640 644 Multi-Media 48 68 180 158

Net Sales

$ 408 $ 459 $ 1,661 $ 1,618

Three Months Ended Twelve Months Ended September 30, June 30, 2016 2015 2016 2015

slide-27
SLIDE 27

Historical Financial Summary ‐ Regions

26

(amounts in millions)

North America $ 190 $ 216 $ 797 $ 738 Europe 211 221 847 821 Asia 24 22 94 59 FX Impact (17) — (77) —

Net Sales

$ 408 $ 459 $ 1,661 $ 1,618 North America $ 189 $ 216 $ 784 $ 738 Europe 196 221 786 821 Asia 23 22 91 59

Net Sales

$ 408 $ 459 $ 1,661 $ 1,618

Three Months Ended Twelve Months Ended September 30, June 30, 2016 2015 2016 2015